| Document and Entity Information | Oct. 02, 2021 |
| Cover [Abstract] | |
| Amendment Flag | false |
| Entity Central Index Key | 0001651431 |
| Document Type | 8-K |
| Document Period End Date | Oct. 2, 2021 |
| Entity Registrant Name | CHECKMATE PHARMACEUTICALS, INC. |
| Entity Incorporation State Country Code | DE |
| Entity File Number | 001-39425 |
| Entity Tax Identification Number | 36-4813934 |
| Entity Address, Address Line One | Checkmate Pharmaceuticals, Inc. |
| Entity Address, Address Line Two | 245 Main Street |
| Entity Address, Address Line Three | 2nd Floor |
| Entity Address, City or Town | Cambridge |
| Entity Address, State or Province | MA |
| Entity Address, Postal Zip Code | 02142 |
| City Area Code | (617) |
| Local Phone Number | 682-3625 |
| Written Communications | false |
| Soliciting Material | false |
| Pre Commencement Tender Offer | false |
| Pre Commencement Issuer Tender Offer | false |
| Security 12b Title | Common Stock, $0.0001 par value per share |
| Trading Symbol | CMPI |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | true |
| Entity Ex Transition Period | false |
